DexCom Receives FDA Warning Letter for Administrative Deficiencies in its MDR Reporting
March 25, 2014 at 08:30 AM EDT
SAN DIEGO---- DexCom, Inc. announced today that it has received a warning letter from the U.S. Food& Drug Administration resulting from a November 2013 inspection of the Company' s facility in San Diego, California by the FDA' s Los Angeles District Office.
